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SUPPLEMENTARY NOTES
ABSTRACT
The cancer preventive properties of individual grape and red wine polyphenols have been investigated. However, such studies focus mainly on individual compounds at concentrations too high to be achieved by dietary intake. In this study, we proposed to test the hypothesis that combined grape and red wine polyphenols at low concentrations can be more effective than individual compounds at inhibition of breast cancer progression. For this, we tested the effects of resveratrol, quercetin, and catechin, which constitute 70% of red wine polyphenols, on biological processes relevant to breast cancer progression using breast cancer cell lines. We found that combined grape polyphenols induce apoptosis and are more effective than individual resveratrol, quercetin, or catechin at inhibition of cell functions that promote breast cancer progression. Using estrogen receptor (ER)α(-), ERβ(+) MDA-MB-231 and ER(-) MDA-MB-435 breast cancer cell lines we demonstrated that combined grape polyphenols increased apoptosis and inhibited cell proliferation, cell cycle progression, and cell migration. Work in the laboratory also showed that combined grape polyphenols reduced primary breast tumor growth and metastasis in nude mice (Castillo-Pichardo, et al., 2009, Clin. Exp. Met. 26:505-16). Studies are underway to identify the molecular targets of grape polyphenols in breast cancer.
SUBJECT TERMS
Grape polyphenols, breast cancer, apoptosis, cell proliferation, cell migration, cell cycle progression
Introduction
Breast cancer is the most commonly diagnosed form of cancer in women 40-55 years of age and is the second major cause of cancer deaths [1] . Metastatic breast cancer, where cancer cells spread by motile mechanisms and establish tumors at distant vital sites, is much harder to eradicate and is often the cause of death from breast cancer. The five year survival rate for metastatic breast cancer is only 26%. Therefore, it is important to investigate strategies for prevention of breast cancer metastasis. Most studies on environmental and dietary anticancer compounds focus on cancer initiation and not the impact of these compounds on metastatic cancer. This proposal is unique in evaluating a role for a dietary compound in breast cancer metastasis, the most deadly aspect of the disease. This timely research is significant to public health by advancing the understanding and treatment of breast cancer metastasis and impact breast cancer patients, those at risk, and survivors of breast cancer. The cancer chemopreventive action of grape products like red wine have been attributed to the antioxidant and antiproliferative properties of polyphenolic compounds. The proposed research will investigate a novel signaling mechanism by which estrogen (E 2 ) like polyphenols from grapes signal to affect breast cancer progression and metastasis using antibody microarrays. Much of the data on the cancer preventive effects of grape polyphenols has been generated from tissue culture cell lines treated with individual polyphenols at concentrations too high to be achieved via dietary consumption. Thus, the utility of polyphenolic compounds as dietary cancer chemopreventives is hampered by their bioavailability at target tissues following consumption. Therefore, prior to clinical development of these polyphenols as cancer chemopreventives it is essential to investigate their mechanism of action at a range of concentrations. This research will identify signaling intermediates of dietary polyphenols with potential for breast cancer therapy. The proposed research will not only impact therapeutic design to combat breast cancer but will also aid in understanding novel signaling mechanisms that directly regulate cell functions relevant for breast cancer metastasis. In addition to such contributions, this project will allow the PI to obtain a Ph.D. degree, which is integral for the pursuit of her long term career goals. The PI plans are to become a researcher and faculty member at a major research institution in order to impact the development of therapeutic targets for treatment and prevention of breast cancer. 
I.
Take comprehensive examination to gain admittance to Ph.D. candidacy.
II.
Write and present Thesis Proposal to Ph.D. Dissertation Committee.
Status: Completed
Task 3. Complete the Dissertation research for Ph.D. Degree
I.
Complete the independent research requirement for the Ph.D. Degree.
II.
Submit two manuscripts for publication in peer-reviewed journals.
III.
Write Ph.D. Dissertation and successfully defend Dissertation. Status: Dissertation research in progress and one research article was published (see appendix).
B. The following statement of work describes the proposed research plan of testing the hypothesis that combined grape polyphenols regulate signal transduction to modulate breast cancer progression to metastasis:
Task 1. Determine the effective concentration for antibodies to be used in the study
Status: A commercially available antibody array that suited the purposes of the proposed project was found. Therefore Task 1 was not necessary. The cytoskeletal phospho-specific antibody microarray from Full Moon Biosystems, Inc. was used. This array includes 95 highly specific and well-characterized phosphorylation antibodies (see appendix for a detailed list) in the cytoskeletal pathway, which are important regulators of migration and invasion, and therefore, of metastasis. The non-phospho pairs are also included to allow a determination of the phosphorylation state of each of these proteins.
Task 2. Determine the effect of individual grape polyphenols on mammary epithelial and breast cancer cells. Task 3. Determine the effect of individual grape polyphenols on breast cancer cells. Task 4. Determine the effect of combined grape polyphenols on breast cancer cells.
Status: Tasks 2-4 propose to delineate signal transduction from individual and combined grape polyphenols to proteins that regulate breast cancer metastasis using antibody microarrays. However, previous to elucidating the effects of grape polyphenols on signal transduction it was necessary to further characterize how these compounds influence biological processes relevant for breast cancer progression and metastasis. Therefore, we decided to study the effects of resveratrol, quercetin, and catechin individually or combined (RQC) at low dietary concentrations on breast cancer cell proliferation, cell cycle progression, apoptosis, and cell migration. The effects of individual and combined resveratrol, quercetin, and catechin on cell proliferation and cell cycle progression of the low metastatic, estrogen receptor (ER)α(+), ERβ(-) MDA-MB-231 cell line were presented on the preliminary data section of the original proposal narrative and have been published in [2] .
Cell proliferation
Previously, we showed that in MDA-MB-231 cells, combined grape polyphenols were more effective than individual compounds at inhibition of cell proliferation and cell cycle progression causing an S to G2 phase arrest of the cell cycle [2] . We then decided to test the effects of grape polyphenols on the highly metastatic, ER negative MDA-MB-435 cell line to address the role of ER in the response to such compounds. MDA-MB-435 cells were treated with vehicle, 0.5, 5, or 20μM resveratrol, quercetin, catechin or RQC every 48h for 96h and cell number was quantified (Fig. 1) . At 0.5μM, treatment with individual resveratrol or catechin did not cause significant changes in cell number, while quercetin caused an increase in cell number. Interestingly, RQC at 0.5μM significantly decreased cell proliferation by approximately 60%. At 5μM none of the individual grape polyphenols inhibited cell proliferation. However, 5μM RQC treatment decreased proliferation by an 80%. At 20μM only resveratrol, quercetin and RQC had an anti-proliferative effect at 20μM. From these results it can be concluded that, as previously shown with MDA-MB-231 cells [2] , combined grape polyphenols at low concentrations are more effective than the individual compounds at inhibiting MDA-MB-435 breast cancer cell proliferation. However, MDA-MB-231 cells showed higher sensitivity to RQC. Cell cycle progression MDA-MB-435 cells were treated with vehicle, 0.5 or 5μM resveratrol, quercetin, catechin or RQC every 48h for 96h. The effect of such treatments on cell cycle progression was determined by flow cytometric analysis of PI-stained cells (Fig. 2) . While individual polyphenols did not show an effect on cell cycle progression, a moderate S phase arrest by RQC treatment at 5μM was observed (Fig. 2B) . The S phase arrest of the MDA-MB-435 cells in response to RQC showed a p≤0.06, which is slightly less significant than the S phase arrest of p≤0.05 observed with MDA-MB-231 cells [2] . Again, combined grape polyphenols were proven to be more effective than individual compounds at inhibition of cell proliferation and cell cycle progression. However, the 80% decrease in MDA-MB-435 cell proliferation induced by 5μM RQC does not correlate with the observed modest increase in cells at S-phase. Therefore, we decided to investigate the effect of RQC treatment on apoptosis by measuring Annexin V staining and caspase 3 activity. 
Apoptosis
The effect of RQC treatment on apoptosis of MDA-MB-435 cells was measured by caspase 3 activity and Annexin V staining (Fig. 3) . This downstream effector caspase was selected to assess the effect of RQC on both receptor-regulated and mitochondrial apoptotic pathways. Combined grape polyphenols at 0.5μM did not affect caspase 3 activity, while 5μM RQC increased caspase 3 activity by two fold with a p≤0.06 thus, implicating RQC treatment in apoptosis induction (Fig. 3A) . This result was confirmed by Annexin V staining, where 44% of RQC-treated cells were shown to be apoptotic, compared to only 6.8% in vehicle-treated cells (Fig. 3B) . Annexin V binds to the phosphatidyl serine residues present on the outer leaflet of the plasma membrane during early apoptosis. The increase in apoptosis induced by RQC suggests that the effect of combined grape polyphenols on cell proliferation might be due not only to cell cycle arrest, but also to induction of apoptosis.
Grape polyphenols inhibit breast cancer cell migration in vitro:
The effect of grape polyphenols on MDA-MB-231 and MDA-MB-435 cell migration, a process critical to metastasis, was analyzed in vitro by a Transwell Assay. Cells were treated with vehicle, 0.5, or 5μM resveratrol, quercetin, catechin, or RQC in serum-free and phenol red-free media. Following 8 hour incubation, the number of cells that actively migrated to the underside of a membrane was quantified (Fig. 4) . In MDA-MB-231 cells, resveratrol and quercetin at 0.5M increased cell migration in a statistically significant manner (Fig.  4A) . The effect of resveratrol is similar to our previous results that reported low concentrations of resveratrol to act comparable to estrogen and increase cell migration [3] . None of the other grape polyphenols significantly changed breast cancer cell migration. At 0.5 and 5M, combined RQC treatment significantly reduced MDA-MB-231 cell migration by ~60% when compared to vehicle controls (Fig. 4A) ; whereas, 0.5M combined RQC treatment reduced MDA-MB-435 cell migration by ~20%, and 5M RQC significantly reduced cell migration by 40% (Fig. 4B) . 
Antibody microarrays
MDA-MB-231 cells were treated for 15min with individual or combined resveratrol, quercetin, and catechin at 5µM each for 15min. Total protein extracts were obtained and biotinylated to later be incubated with the arrays. Finally, detection was achieved by incubation of the arrays with streptavidin coupled to the fluorescent dye Cy3. The experiment with the combined polyphenols was conducted three times but unfortunately, reproducibility was not achieved. Nevertheless, western blots were conducted for some of the proteins found to be regulated by RQC after array data analysis (Fig. 5 ). We were able to confirm that the phosphorylation and therefore, activation of the Ser/Ther protein kinase Akt was reduced by 5µM RQC treatment for 15min not only in the MDA-MB-231 but also in the ER negative and highly metastatic breast cancer cell line MDA-MB-435 ( The PI3K/Akt pathway regulates multiple cellular processes important for tumorigenesis such as cell growth, cell proliferation, cell migration, and survival. This pathway is also integral for the epithelial to mesenchymal transition which in cancer cells is indicative of aggressiveness and invasive potential [5, 6] . The observed effect of RQC on Akt activity suggests that the possible mechanism by which combined grape polyphenols resveratrol, quercetin and catechin inhibit breast cancer cell proliferation is via S phase arrest and reduced cell survival signaling. 
Conclusion
The data presented above demonstrates that combined grape polyphenols are more effective than individual compounds at inhibiting biological functions relevant for breast cancer progression, such as cell proliferation, cell cycle progression and cell migration on both estrogen receptor (ER)α(-), ERβ(+) MDA-MB-231 and ER(-) MDA-MB-435 breast cancer cell lines. Akt mediated survival signaling was also reduced by combined grape polyphenols on both cell lines. Additionally, combined grape polyphenols were shown to be effective at induction of apoptosis in MDA-MB-435 cells. However, the effect of combined grape polyphenols was more prominent on MDA-MB-231 than in MDA-MB-435 cells. This difference in response was expected since MDA-MB-435 cells are characterized by having a more aggressive phenotype and are known to be highly metastatic. This finding suggests that grape polyphenols may be acting as antiestrogenic compounds in the MDA-MB-231 cells since this cell line expresses the ERβ isoform and MDA-MB-435 cells are ER negative. Also, since MDA-MB-435 cells are Her2 overexpressing it is possible that combined grape polyphenols are not as efficient at inhibiting the increased Her-2 signaling in this highly aggressive cancer cell line. However, mechanistic studies need to be conducted to further address the differences in response to grape polyphenols between these two cancer cell lines.
